Concepts (246)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neural Tube Defects | 17 | 2024 | 372 | 2.190 |
Why?
|
| Folic Acid | 15 | 2024 | 285 | 1.930 |
Why?
|
| Folate Receptor 1 | 8 | 2024 | 30 | 1.220 |
Why?
|
| Oxazines | 2 | 2024 | 30 | 1.000 |
Why?
|
| Pyridones | 2 | 2024 | 144 | 0.910 |
Why?
|
| Piperazines | 2 | 2024 | 268 | 0.870 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 2 | 2024 | 43 | 0.820 |
Why?
|
| Spinal Dysraphism | 5 | 2022 | 277 | 0.790 |
Why?
|
| Sertraline | 2 | 2020 | 45 | 0.750 |
Why?
|
| Zebrafish | 3 | 2019 | 422 | 0.660 |
Why?
|
| Autoantibodies | 6 | 2018 | 456 | 0.620 |
Why?
|
| Folic Acid Deficiency | 5 | 2024 | 50 | 0.590 |
Why?
|
| Neural Tube | 3 | 2020 | 44 | 0.590 |
Why?
|
| Zebrafish Proteins | 1 | 2019 | 130 | 0.570 |
Why?
|
| Pregnancy | 19 | 2024 | 7558 | 0.540 |
Why?
|
| Embryonic Stem Cells | 2 | 2020 | 160 | 0.530 |
Why?
|
| Neural Crest | 1 | 2017 | 52 | 0.520 |
Why?
|
| Receptors, Cell Surface | 6 | 2013 | 428 | 0.520 |
Why?
|
| Antidepressive Agents | 1 | 2017 | 327 | 0.440 |
Why?
|
| Mice | 24 | 2024 | 18410 | 0.420 |
Why?
|
| HIV Infections | 2 | 2024 | 2031 | 0.420 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-2 | 1 | 2014 | 19 | 0.420 |
Why?
|
| Teratogens | 4 | 2018 | 86 | 0.410 |
Why?
|
| Gene Expression Profiling | 3 | 2012 | 1821 | 0.360 |
Why?
|
| Toxicity Tests | 3 | 2020 | 36 | 0.340 |
Why?
|
| Animals | 29 | 2024 | 34278 | 0.330 |
Why?
|
| Disease Models, Animal | 6 | 2020 | 4681 | 0.300 |
Why?
|
| Carrier Proteins | 4 | 2010 | 1021 | 0.300 |
Why?
|
| Paroxetine | 2 | 2020 | 24 | 0.290 |
Why?
|
| Cell Line | 5 | 2020 | 2596 | 0.280 |
Why?
|
| Environmental Pollutants | 2 | 2020 | 77 | 0.270 |
Why?
|
| Valproic Acid | 4 | 2018 | 161 | 0.270 |
Why?
|
| Folate Receptors, GPI-Anchored | 5 | 2018 | 54 | 0.260 |
Why?
|
| Tacrolimus Binding Proteins | 2 | 2020 | 72 | 0.260 |
Why?
|
| Repressor Proteins | 2 | 2022 | 778 | 0.260 |
Why?
|
| Embryonic Development | 2 | 2019 | 223 | 0.250 |
Why?
|
| Vitamin B 12 | 2 | 2013 | 59 | 0.240 |
Why?
|
| Nervous System | 2 | 2004 | 123 | 0.230 |
Why?
|
| Epitope Mapping | 1 | 2025 | 78 | 0.230 |
Why?
|
| Fumonisins | 1 | 2004 | 2 | 0.230 |
Why?
|
| Homeodomain Proteins | 3 | 2020 | 566 | 0.230 |
Why?
|
| Immunoglobulin G | 4 | 2025 | 810 | 0.220 |
Why?
|
| Embryo, Nonmammalian | 3 | 2018 | 139 | 0.210 |
Why?
|
| Mice, Inbred C57BL | 10 | 2020 | 4738 | 0.200 |
Why?
|
| Female | 24 | 2025 | 70755 | 0.200 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2025 | 218 | 0.200 |
Why?
|
| Central Nervous System | 1 | 2004 | 284 | 0.190 |
Why?
|
| Loss of Function Mutation | 2 | 2020 | 160 | 0.190 |
Why?
|
| Homocysteine | 2 | 2016 | 118 | 0.190 |
Why?
|
| Proton-Coupled Folate Transporter | 2 | 2012 | 6 | 0.180 |
Why?
|
| Pseudomonas Infections | 1 | 2023 | 116 | 0.180 |
Why?
|
| Embryo, Mammalian | 5 | 2016 | 446 | 0.180 |
Why?
|
| Anticonvulsants | 5 | 2020 | 384 | 0.170 |
Why?
|
| Wnt3A Protein | 1 | 2020 | 11 | 0.170 |
Why?
|
| Tetrahydrofolates | 1 | 2020 | 16 | 0.170 |
Why?
|
| Cerebrum | 1 | 2020 | 34 | 0.160 |
Why?
|
| Humans | 26 | 2025 | 130931 | 0.160 |
Why?
|
| Organotin Compounds | 1 | 2020 | 6 | 0.160 |
Why?
|
| Mice, Transgenic | 3 | 2018 | 2358 | 0.160 |
Why?
|
| Citalopram | 1 | 2020 | 29 | 0.160 |
Why?
|
| Mice, Inbred ICR | 1 | 2020 | 151 | 0.160 |
Why?
|
| HIV Integrase Inhibitors | 1 | 2019 | 14 | 0.160 |
Why?
|
| Abnormalities, Drug-Induced | 3 | 2018 | 98 | 0.150 |
Why?
|
| Pneumonia | 1 | 2023 | 342 | 0.150 |
Why?
|
| Antibodies, Monoclonal | 1 | 2025 | 1006 | 0.150 |
Why?
|
| Teratogenesis | 1 | 2018 | 8 | 0.150 |
Why?
|
| Antibodies, Viral | 1 | 2025 | 1166 | 0.150 |
Why?
|
| Membrane Transport Proteins | 2 | 2018 | 185 | 0.140 |
Why?
|
| Dietary Supplements | 2 | 2019 | 448 | 0.140 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2018 | 34 | 0.140 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2007 | 1000 | 0.140 |
Why?
|
| Formates | 1 | 2018 | 7 | 0.140 |
Why?
|
| Amides | 1 | 2018 | 90 | 0.140 |
Why?
|
| Nervous System Diseases | 2 | 2020 | 400 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2021 | 484 | 0.140 |
Why?
|
| Transcription Factor AP-2 | 1 | 2017 | 22 | 0.140 |
Why?
|
| Models, Animal | 1 | 2019 | 459 | 0.140 |
Why?
|
| Gene Expression | 4 | 2020 | 1500 | 0.130 |
Why?
|
| Anencephaly | 1 | 2016 | 11 | 0.120 |
Why?
|
| Thymus Gland | 2 | 2013 | 102 | 0.120 |
Why?
|
| Meningomyelocele | 1 | 2019 | 270 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2020 | 3397 | 0.120 |
Why?
|
| Cardiovascular System | 1 | 2016 | 103 | 0.120 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 704 | 0.120 |
Why?
|
| Cell Proliferation | 3 | 2018 | 2459 | 0.110 |
Why?
|
| Blood Proteins | 1 | 2016 | 137 | 0.110 |
Why?
|
| Autoimmunity | 1 | 2016 | 181 | 0.110 |
Why?
|
| Fetoscopy | 1 | 2019 | 462 | 0.110 |
Why?
|
| Reduced Folate Carrier Protein | 1 | 2014 | 19 | 0.110 |
Why?
|
| Microarray Analysis | 2 | 2012 | 226 | 0.100 |
Why?
|
| Cell Movement | 1 | 2017 | 874 | 0.100 |
Why?
|
| Endocytosis | 1 | 2014 | 130 | 0.100 |
Why?
|
| Mice, Knockout | 8 | 2020 | 3850 | 0.100 |
Why?
|
| Glycerol-3-Phosphate O-Acyltransferase | 1 | 2012 | 1 | 0.100 |
Why?
|
| Glycerophospholipids | 1 | 2012 | 7 | 0.100 |
Why?
|
| Thymocytes | 1 | 2012 | 9 | 0.100 |
Why?
|
| Endothelial Cells | 1 | 2016 | 536 | 0.100 |
Why?
|
| Stilbenes | 1 | 2013 | 37 | 0.100 |
Why?
|
| Anti-Obesity Agents | 1 | 2013 | 46 | 0.100 |
Why?
|
| Tight Junctions | 1 | 2012 | 38 | 0.100 |
Why?
|
| PAX3 Transcription Factor | 1 | 2012 | 29 | 0.100 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2013 | 45 | 0.100 |
Why?
|
| Paired Box Transcription Factors | 1 | 2012 | 75 | 0.100 |
Why?
|
| Gene Knockout Techniques | 1 | 2012 | 132 | 0.090 |
Why?
|
| Central Nervous System Diseases | 1 | 2013 | 98 | 0.090 |
Why?
|
| Genomics | 1 | 2020 | 1617 | 0.090 |
Why?
|
| Blood-Brain Barrier | 1 | 2012 | 147 | 0.090 |
Why?
|
| Risk | 2 | 2016 | 738 | 0.090 |
Why?
|
| Case-Control Studies | 5 | 2020 | 3433 | 0.090 |
Why?
|
| Immunoglobulin M | 2 | 2010 | 213 | 0.090 |
Why?
|
| Diet, High-Fat | 1 | 2013 | 262 | 0.090 |
Why?
|
| Genetic Variation | 1 | 2018 | 1559 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2020 | 2430 | 0.080 |
Why?
|
| Biological Transport, Active | 3 | 2018 | 73 | 0.080 |
Why?
|
| Cleft Palate | 2 | 2011 | 219 | 0.080 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 2344 | 0.070 |
Why?
|
| Hyperhomocysteinemia | 1 | 2009 | 37 | 0.070 |
Why?
|
| Mutation | 2 | 2020 | 6144 | 0.070 |
Why?
|
| Obesity | 2 | 2013 | 2377 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 1396 | 0.070 |
Why?
|
| Arsenic | 1 | 2006 | 36 | 0.060 |
Why?
|
| Risk Factors | 4 | 2020 | 10901 | 0.060 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 2025 | 35 | 0.060 |
Why?
|
| Adult | 6 | 2025 | 31541 | 0.050 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 2 | 2018 | 64 | 0.050 |
Why?
|
| Cell Polarity | 1 | 2024 | 119 | 0.050 |
Why?
|
| Bone and Bones | 1 | 2005 | 306 | 0.050 |
Why?
|
| Diabetes Complications | 1 | 2004 | 199 | 0.050 |
Why?
|
| Amikacin | 1 | 2023 | 25 | 0.050 |
Why?
|
| Carnitine O-Palmitoyltransferase | 2 | 2013 | 28 | 0.050 |
Why?
|
| Heart | 1 | 2007 | 674 | 0.050 |
Why?
|
| Maternal Exposure | 1 | 2004 | 150 | 0.050 |
Why?
|
| NIH 3T3 Cells | 1 | 2022 | 96 | 0.050 |
Why?
|
| Wnt Signaling Pathway | 1 | 2024 | 205 | 0.050 |
Why?
|
| Genetic Techniques | 1 | 2002 | 99 | 0.050 |
Why?
|
| Fever | 1 | 2004 | 311 | 0.050 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2004 | 266 | 0.050 |
Why?
|
| Organ Size | 2 | 2013 | 435 | 0.040 |
Why?
|
| Actins | 1 | 2024 | 316 | 0.040 |
Why?
|
| Genome | 1 | 2004 | 472 | 0.040 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2023 | 174 | 0.040 |
Why?
|
| Receptor, Muscarinic M1 | 1 | 2021 | 5 | 0.040 |
Why?
|
| Antibodies, Neutralizing | 1 | 2025 | 515 | 0.040 |
Why?
|
| Integrin alpha Chains | 1 | 2021 | 15 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2022 | 694 | 0.040 |
Why?
|
| Neuroaxonal Dystrophies | 1 | 2020 | 16 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2023 | 365 | 0.040 |
Why?
|
| Neurulation | 1 | 2020 | 20 | 0.040 |
Why?
|
| Odds Ratio | 2 | 2016 | 1233 | 0.040 |
Why?
|
| Male | 8 | 2025 | 64823 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2023 | 844 | 0.040 |
Why?
|
| Fibroblast Growth Factors | 1 | 2021 | 168 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2024 | 861 | 0.040 |
Why?
|
| Swine | 1 | 2023 | 1188 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2020 | 418 | 0.040 |
Why?
|
| Nervous System Malformations | 1 | 2020 | 129 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2021 | 345 | 0.040 |
Why?
|
| Gestational Age | 2 | 2016 | 1215 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2021 | 418 | 0.040 |
Why?
|
| Sheep | 1 | 2019 | 225 | 0.040 |
Why?
|
| Logistic Models | 2 | 2016 | 1822 | 0.040 |
Why?
|
| Adiposity | 1 | 2020 | 207 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2020 | 660 | 0.040 |
Why?
|
| Homocystinuria | 1 | 2018 | 26 | 0.030 |
Why?
|
| Fetal Death | 1 | 2018 | 119 | 0.030 |
Why?
|
| Muscle Spasticity | 1 | 2018 | 56 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2020 | 802 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2022 | 925 | 0.030 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2020 | 239 | 0.030 |
Why?
|
| Teratoma | 1 | 2018 | 123 | 0.030 |
Why?
|
| Pedigree | 1 | 2020 | 1703 | 0.030 |
Why?
|
| Congenital Abnormalities | 1 | 2020 | 319 | 0.030 |
Why?
|
| Psychotic Disorders | 1 | 2018 | 153 | 0.030 |
Why?
|
| DNA Repair | 1 | 2020 | 563 | 0.030 |
Why?
|
| DNA Damage | 1 | 2020 | 523 | 0.030 |
Why?
|
| Drug Tolerance | 1 | 2016 | 40 | 0.030 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2016 | 106 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2020 | 3675 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2013 | 1625 | 0.030 |
Why?
|
| Cell Survival | 1 | 2018 | 850 | 0.030 |
Why?
|
| Diet | 2 | 2016 | 1115 | 0.030 |
Why?
|
| Heart Defects, Congenital | 1 | 2007 | 1892 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2016 | 331 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2016 | 382 | 0.030 |
Why?
|
| China | 1 | 2016 | 286 | 0.030 |
Why?
|
| Fetus | 1 | 2018 | 584 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2020 | 2965 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2020 | 1741 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 790 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 1235 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2021 | 1082 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2016 | 353 | 0.030 |
Why?
|
| Apoptosis | 1 | 2020 | 1852 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2007 | 1009 | 0.030 |
Why?
|
| Polychlorinated Dibenzodioxins | 1 | 2012 | 6 | 0.020 |
Why?
|
| Leucovorin | 1 | 2012 | 54 | 0.020 |
Why?
|
| Vitamin B Complex | 1 | 2012 | 40 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2012 | 365 | 0.020 |
Why?
|
| Norway | 1 | 2011 | 29 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2012 | 172 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2023 | 2558 | 0.020 |
Why?
|
| Erythropoiesis | 1 | 2011 | 38 | 0.020 |
Why?
|
| Pancytopenia | 1 | 2011 | 41 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2011 | 97 | 0.020 |
Why?
|
| Intestinal Absorption | 1 | 2011 | 170 | 0.020 |
Why?
|
| Denmark | 1 | 2010 | 29 | 0.020 |
Why?
|
| Gene Targeting | 1 | 2011 | 170 | 0.020 |
Why?
|
| DNA Primers | 1 | 2011 | 609 | 0.020 |
Why?
|
| Spleen | 1 | 2011 | 256 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2013 | 495 | 0.020 |
Why?
|
| Neurons | 1 | 2020 | 1978 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2013 | 373 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2012 | 772 | 0.020 |
Why?
|
| Maternal Age | 1 | 2010 | 137 | 0.020 |
Why?
|
| Pregnancy Trimester, First | 1 | 2010 | 120 | 0.020 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2009 | 14 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 1383 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2011 | 314 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 2849 | 0.020 |
Why?
|
| Body Weight | 1 | 2013 | 986 | 0.020 |
Why?
|
| Methionine | 1 | 2009 | 96 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2021 | 4645 | 0.020 |
Why?
|
| Cleft Lip | 1 | 2011 | 190 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2020 | 8542 | 0.020 |
Why?
|
| Base Sequence | 1 | 2011 | 2781 | 0.020 |
Why?
|
| Ephrins | 1 | 2006 | 4 | 0.020 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2006 | 44 | 0.020 |
Why?
|
| RNA, Antisense | 1 | 2005 | 35 | 0.010 |
Why?
|
| Biological Transport | 1 | 2006 | 332 | 0.010 |
Why?
|
| Middle Aged | 1 | 2025 | 28735 | 0.010 |
Why?
|
| Pharmacogenetics | 1 | 2005 | 201 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2004 | 66 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 2004 | 155 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2013 | 1768 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 2004 | 125 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2004 | 299 | 0.010 |
Why?
|
| Multigene Family | 1 | 2004 | 289 | 0.010 |
Why?
|
| Heterozygote | 1 | 2004 | 726 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2004 | 1067 | 0.010 |
Why?
|
| Liver | 1 | 2009 | 1790 | 0.010 |
Why?
|
| Brain | 1 | 2013 | 3161 | 0.010 |
Why?
|
| Infant | 1 | 2016 | 13210 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2006 | 2575 | 0.010 |
Why?
|
| Age Factors | 1 | 2006 | 2866 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2010 | 6443 | 0.010 |
Why?
|
| Phenotype | 1 | 2005 | 4493 | 0.010 |
Why?
|